Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
SeraCare™ ACCURUN™ 676 Cystic Fibrosis Extended Control
A synthetic, multiplex control formulated for research use in laboratory testing, molecular screening, and mutation testing, with assays that identify mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
Supplier: SeraCare™ 20400009
Description
- Eliminates errors arising from use of rotating gDNA control schemes with incomplete mutation profiles
- Controls contain a mixture of oligonucleotides that produce a call for every mutation tested
- ACCURUN 676 covers 34 mutations, and when used in conjunction with ACCURUN 644, covers all 81 mutations in the Prima xTAG™ CFTR 70+6 Assay
- All mutations contained in a single vial
- High purity, large lots, stable materials–no additional processing required
Not for use in diagnostic procedures
Specifications
| RUO | |
| ACCURUN 676 Cystic Fibrosis Extended Control | |
| Detects significant errors with the use of rotating gDNA control schemes, research use only | |
| 100 μL |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction